It's a game that myself and the others invested here are happy to play! I think people that invest in biotechs are well aware about the need for ongoing funding, that's the name of the game, and inevitably some will fail. High risk high reward.
The pre-clinical science here is quite exciting. The delays have been hugely costly.
Ann: Further update on PAT-DX1 GMP manufacturing run, page-36
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
-0.001(14.3%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $4.138K | 689.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 806629 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3743101 | 5 |
View Market Depth
| Last trade - 12.11pm 12/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |